Tech Company Financing Transactions
Asgard Therapeutics Funding Round
European Innovation Council Fund joined a $2.7 million funding round for Asgard Therapeutics. The round was announced on 11/19/2026.
Transaction Overview
Company Name
Announced On
11/19/2026
Transaction Type
Debt
Amount
$2,700,000
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed.
Company Information
Company Status
Private & Independent
Industry
Healthcare Services
Mailing Address
Medicon Village
Lund, 223 81
Sweden
Lund, 223 81
Sweden
Phone
Website
Email Address
Overview
Asgard Therapeutic's mission is to pioneer direct cell reprogramming for cancer immunotherapy. Our current focus is to develop scalable reprogramming technologies enabling the direct in vivo conversion of cancer cells into professional antigen-presenting dendritic cells, reinstating cancer immunity.
Management Team
Title
Name
Email & Social
Browse more venture capital transactions:
Prev: 11/19/2026: Agro Reply venture capital transaction
Next: 11/19/2026: LATO venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. All VC database entries reported here are sourced from news reports and company announcements. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs








